VILELLA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 6.595
AS - Asia 3.737
EU - Europa 3.148
SA - Sud America 551
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
Totale 14.148
Nazione #
US - Stati Uniti d'America 6.401
SG - Singapore 1.104
IT - Italia 1.035
CN - Cina 994
GB - Regno Unito 932
BR - Brasile 428
HK - Hong Kong 421
VN - Vietnam 413
DE - Germania 211
SE - Svezia 208
BD - Bangladesh 195
FI - Finlandia 144
KR - Corea 140
RU - Federazione Russa 130
FR - Francia 101
CA - Canada 97
TR - Turchia 96
IN - India 89
UA - Ucraina 85
ID - Indonesia 57
MX - Messico 52
AR - Argentina 46
NL - Olanda 46
BG - Bulgaria 42
ZA - Sudafrica 39
ES - Italia 35
JP - Giappone 34
LT - Lituania 28
IQ - Iraq 27
IE - Irlanda 26
EC - Ecuador 22
PL - Polonia 22
BE - Belgio 20
PK - Pakistan 20
CL - Cile 18
CO - Colombia 18
AT - Austria 16
AE - Emirati Arabi Uniti 15
UZ - Uzbekistan 15
MY - Malesia 14
RO - Romania 12
IR - Iran 11
TN - Tunisia 10
CZ - Repubblica Ceca 9
IL - Israele 9
JO - Giordania 9
NO - Norvegia 9
PH - Filippine 9
SA - Arabia Saudita 9
AU - Australia 8
DZ - Algeria 8
EU - Europa 8
CU - Cuba 7
EG - Egitto 7
KZ - Kazakistan 7
MA - Marocco 7
TH - Thailandia 7
AN - Antille olandesi 6
DO - Repubblica Dominicana 6
KE - Kenya 6
LB - Libano 6
NP - Nepal 6
PY - Paraguay 6
VE - Venezuela 6
AL - Albania 5
AZ - Azerbaigian 5
CH - Svizzera 5
PA - Panama 5
PT - Portogallo 5
TW - Taiwan 5
AO - Angola 4
BO - Bolivia 4
HN - Honduras 4
JM - Giamaica 4
OM - Oman 4
SN - Senegal 4
BH - Bahrain 3
CR - Costa Rica 3
ET - Etiopia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
PR - Porto Rico 2
TG - Togo 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 14.128
Città #
Ashburn 774
Southend 679
Santa Clara 638
Singapore 602
Fairfield 471
Hong Kong 415
Chandler 384
Hefei 371
San Jose 334
Woodbridge 293
Houston 218
Seattle 214
Modena 211
Beijing 195
Chicago 181
Ann Arbor 179
Wilmington 172
Los Angeles 152
Cambridge 151
Dearborn 141
Ho Chi Minh City 137
Nyköping 135
Council Bluffs 129
London 129
Seoul 128
Jacksonville 124
Helsinki 105
New York 105
Hanoi 94
The Dalles 84
Bologna 62
Milan 57
Como 55
Munich 51
Izmir 46
São Paulo 44
Lauterbourg 43
Princeton 42
Salt Lake City 42
Buffalo 40
Jakarta 40
Rome 40
Sofia 40
San Diego 37
Dallas 35
Moscow 35
Eugene 33
Parma 32
Orem 31
Chennai 28
Reggio Emilia 28
Redwood City 26
Tokyo 26
Frankfurt am Main 24
Kocaeli 22
Boardman 21
Brooklyn 21
Da Nang 21
Guangzhou 21
Mexico City 21
Shanghai 21
Montreal 20
Phoenix 20
Toronto 20
Boston 19
Johannesburg 19
Atlanta 18
Columbus 18
Warsaw 18
Dublin 17
Elk Grove Village 17
Fremont 17
Tampa 17
Haiphong 16
Stockholm 16
Brussels 14
Poplar 14
Amsterdam 13
Brasília 13
Bremen 13
Correggio 13
Manchester 13
Quito 13
Tashkent 13
Lancaster 12
Redondo Beach 12
Sterling 12
Tulare 12
Zhengzhou 12
Baghdad 11
Madison 11
Naples 11
Nuremberg 11
Washington 11
Kent 10
Norwalk 10
Ottawa 10
Santiago 10
Turku 10
Vancouver 10
Totale 9.576
Nome #
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 431
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 401
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice 381
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 370
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 369
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 368
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 362
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 360
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 349
Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors 341
Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice 337
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 336
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 330
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 327
In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 319
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 315
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 315
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 313
DAT atypical inhibitors as novel antipsychotic drugs 299
Astrocyte-targeted production of IL-10 induces changes in microglial reactivity and reduces motor neuron death after facial nerve axotomy 298
Neuronal and extraneuronal nicotinic acetylcholine receptors 281
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 276
A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice 276
Brain targeting by engineered nanoparticles 274
Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo 268
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 263
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 258
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 257
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 254
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 252
Nanotechnology and Central Nervous System Drug Delivery 249
Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10 237
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 231
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease 229
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 211
Female mice exhibit similar long-term plasticity and microglial properties between the dorsal and ventral hippocampal poles 206
Dorsal and ventral striatal neuronal subpopulations differentially disrupt male mouse copulatory behavior 198
S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis 198
Implantable and Bioresorbable Nanostructured Fluorescence Sensor for In vivo pH Monitoring 183
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease 182
Targeting Metal Homeostasis as a Therapeutic Strategy for Alzheimer’s Disease 178
MicroRNA-218 instructs proper assembly of hippocampal networks 177
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells 172
Nanomedicine in neurodegenerative disorders: Understanding the journey 167
Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice 160
Placebo effect between evidence and myths: How to distinguish true from fake news 145
Long-term behavioral and histological profile following CA3 ventral lesion 143
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 136
Two minimally invasive strategies to implant guide cannulas for multiple injections in deep brain areas 132
The Role of Trace Metals in Alzheimer’s Disease 132
Targeted metabolomics for the analysis of p-cresol in mouse brain by HPLC-ESI-MS/MS 130
Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain 125
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS 120
Una nuova strategia per ingannare la barriera emato-encefalica: studio in vivo di captazione, distribuzione e trasporto di nanoparticelle nel cervello. 79
Reference gene variability across age and sex in 5XFAD mice highlights normalization challenges in Alzheimer’s models 40
Thermally Degradable Biocompatible Hydrogel as Transient Encapsulation Coating for Implantable Sensors 30
Multiparametric Bioresorbable Sensor for Doxorubicin Detection via Molecularly Imprinted Synthetic Receptors 27
DevelopmentofaBiodegradableGreenEmitterChitosan-Based OLEDfor ImplantableBiomedicalDevices 23
In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor. 18
Totale 14.274
Categoria #
all - tutte 55.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022850 39 50 87 38 28 37 33 67 101 78 170 122
2022/2023959 104 128 93 90 104 106 13 103 110 15 50 43
2023/2024696 29 33 59 77 149 51 64 78 16 15 48 77
2024/20252.626 95 26 56 160 434 368 222 162 212 194 353 344
2025/20265.562 394 202 382 672 958 322 562 256 533 522 493 266
2026/2027111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 14.274